Qol-28. Cancer-Related Distress In Neuro-Oncology: Patients Inform Program Development For Enhancing Quality Of Life
Amber Fox,Giuliana V Zarrella,Ashlee R Loughan,Autumn Lanoye,Oxana Palesh,F Gerard Moeller,Sarah E Braun
DOI: https://doi.org/10.1093/neuonc/noae165.1063
2024-11-29
Neuro-Oncology
Abstract:BACKGROUNDBrain tumor diagnosis and treatment result in significant negative sequelae, including cognitive decline, fatigue, and psychosocial symptoms. This study aimed to identify brain tumor patients' sources of cancer-related distress and examine their interest in various treatment modalities targeting cognitive decline to inform program development for this underserved population. METHODSIn pursuit of program development, patients with both primary and secondary brain tumors completed an anonymous survey. They reported demographics, tumor characteristics, subjective cognitive functioning; and, rated sources of cancer-related symptom distress (i.e., cognitive changes, fatigue, physical symptoms, motor functioning, balance, mood, and relationship) and interest in treatments targeting cancer-related cognitive decline (i.e., cognitive rehabilitation, mindfulness-based practices, psychotherapy, and medication). Descriptive statistics, t-tests, chi-square, and linear regressions were conducted. RESULTSAmong participants ( N =137, M age =49.6±15.8, 58.1% female, 84.8% White), 50.4% endorsed subjective cognitive functioning below the mean (M FACT-Br-CI =22.6±7.5). Nearly half reported significant distress due to cancer-related fatigue (49.6%) and cognitive change (48.9%). Patients' mean severity of distress due to cognitive decline was significantly greater relative to all other cancer-related symptoms ( p s<.001), except fatigue ( p >.05). Age, gender, or time since diagnosis were not significant predictors ( p s>.05) of distress due to cognitive decline. Most patients with distress due to cognitive change were interested in cognitive rehabilitation (63.6%) and mindfulness-based practices (61.6%), and only 40.4% were interested in medication. Interest in cognitive rehabilitation was not predicted by symptom distress, subjective cognitive functioning, age, gender, or time since diagnosis ( p s>.05). Gender was the only significant predictor of interest in mindful movement ( b =.18, p =.041), with greater interest among women ( χ 2 (1)=4.65, p =.031). CONCLUSIONSFatigue and cognitive decline were the most distressing cancer-related symptoms for neuro-oncology patients. These findings emphasize the need for integrated interventions, including cognitive rehabilitation and mindfulness, as well as multi-targeted and individualized treatments for fatigue and cognitive decline in neuro-oncology.
oncology,clinical neurology